Which has grown faster, BNTX or DXCM?

Over the past five years, DXCM grew revenue faster — BNTX at a 2.16% CAGR versus DXCM at 18.91%.

Is BNTX or DXCM more profitable?

DXCM runs the higher net margin — BNTX at -44.73% versus DXCM at 19.31%.

Which has been the better investment, BNTX or DXCM?

Over the past 5-year, DXCM delivered the higher annualized total return — BNTX at -17.39% versus DXCM at 15.40%. Past performance doesn't predict future results.

BioNTech SE (BNTX) vs DexCom, Inc. (DXCM)

DXCM leads on 7 of 10 compared metrics.

A side-by-side comparison of BioNTech SE and DexCom, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — BNTX vs DXCM

growth of $100 · last 7y

BNTX +535.8%DXCM +95.2%BNTX compounded faster

BNTX DXCM

BNTX vs DXCM: by the numbers

•DXCM is the larger company ($29.08B vs $22.90B market cap).
•DXCM is profitable (19.31% net margin) while BNTX runs a net loss (-44.73%).
•DXCM grew revenue faster over the past five years (18.91% vs 2.16% CAGR).

Which is better, BNTX or DXCM?

Metric tally: BNTX 3 · DXCM 7

It depends on what you're optimizing for:

GrowthDXCM(faster 5Y revenue CAGR)

QualityDXCM(higher ROIC)

Valuation

Metric	BNTX	DXCM
P/E ratio	—	32.21
Forward P/E	—	24.42
P/S ratio	6.97	6.16●
P/B ratio	1.06●	10.03
PEG ratio	—	0.66
EV / EBITDA	—	20.28
FCF yield	6.53%●	4.82%

Profitability

Metric	BNTX	DXCM
Gross margin	73.26%●	61.84%
Operating margin	-51.55%	21.45%●
Net margin	-44.73%	19.31%●
ROE	-6.79%	31.47%●
ROIC	-3.14%	16.61%●

Growth (annualized)

Metric	BNTX	DXCM
Revenue CAGR (5Y)	2.16%	18.91%●
EPS CAGR (5Y)	—	10.31%
FCF CAGR (5Y)	—	43.37%
Total return CAGR (5Y)	-17.39%	-5.51%●

Frequently asked

Which is better, BNTX or DXCM?: It depends on your goal. growth: DXCM (faster 5Y revenue CAGR); quality: DXCM (higher ROIC). Across all compared metrics, DXCM leads 7 to 3.
Which has grown faster, BNTX or DXCM?: Over the past five years, DXCM grew revenue faster — BNTX at a 2.16% CAGR versus DXCM at 18.91%.
Is BNTX or DXCM more profitable?: DXCM runs the higher net margin — BNTX at -44.73% versus DXCM at 19.31%.
Which has been the better investment, BNTX or DXCM?: Over the past 5-year, DXCM delivered the higher annualized total return — BNTX at -17.39% versus DXCM at 15.40%. Past performance doesn't predict future results.

Go deeper

Full BNTX analysis Full DXCM analysis Interactive comparison tool

Dig into the metrics

BioNTech SE P/E ratio DexCom P/E ratio BioNTech SE dividend yield DexCom dividend yield BioNTech SE ROE DexCom ROE BioNTech SE operating margin DexCom operating margin BioNTech SE revenue growth DexCom revenue growth BioNTech SE free cash flow DexCom free cash flow

BioNTech SE & DexCom appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.